Compare · SYK vs XAGE
SYK vs XAGE
Side-by-side comparison of Stryker Corporation (SYK) and Longevity Health Holdings Inc. (XAGE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both SYK and XAGE operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- SYK carries a market cap of $125.43B.
- Over the past year, SYK is down 10.8% and XAGE is down 51.1% - SYK leads by 40.3 points.
- SYK has been more active in the news (5 items in the past 4 weeks vs 3 for XAGE).
- SYK has more recent analyst coverage (25 ratings vs 0 for XAGE).
- Company
- Stryker Corporation
- Longevity Health Holdings Inc.
- Price
- $327.50-0.63%
- $2.32-15.02%
- Market cap
- $125.43B
- -
- 1M return
- -0.03%
- +0.00%
- 1Y return
- -10.77%
- -51.05%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NYSE
- NASDAQ
- IPO
- 2021
- News (4w)
- 5
- 3
- Recent ratings
- 25
- 0
Stryker Corporation
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Latest SYK
- Berger Montague PC Investigates Stryker Corporation's Board of Directors for Breach of Fiduciary Duty (NYSE: SYK)
- Berger Montague PC Investigates Stryker Corporation's Board of Directors for Breach of Fiduciary Duty (NYSE: SYK)
- Leerink Partners initiated coverage on Stryker with a new price target
- Stryker signs definitive agreement to acquire Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio
- Amendment: Stryker Corporation filed SEC Form 8-K: Regulation FD Disclosure
- Stryker to announce financial results for its first quarter of fiscal year 2026
- Stryker names Nick Mead Vice President, Investor Relations
- Amendment: SEC Form SCHEDULE 13G/A filed by Stryker Corporation
- SEC Form 4 filed by Stiles Spencer S
- SEC Form 4 filed by Pierce James Andrew
Latest XAGE
- SEC Form SCHEDULE 13D filed by Longevity Health Holdings Inc.
- SEC Form 4 filed by Ajjarapu J. Ram
- SEC Form 3 filed by new insider Ajjarapu J. Ram
- SEC Form 424B3 filed by Longevity Health Holdings Inc.
- SEC Form 10-K filed by Longevity Health Holdings Inc.
- Longevity Health Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Longevity Health Holdings Closes Strategic Investment and Appoints Ram Ajjarapu as Chairman and CEO to Drive Acquisition-Focused Growth
- SEC Form 424B3 filed by Longevity Health Holdings Inc.
- Longevity Health Holdings Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement
- SEC Form 25-NSE filed by Longevity Health Holdings Inc.